A Systematic Review of Artificial Intelligence in Prostate Cancer
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The diagnosis and management of prostate cancer involves the interpretation of data from multiple modalities to aid in decision making. Tools like PSA levels, MRI guided biopsies, genomic biomarkers, and Gleason grading are used to diagnose, risk stratify, and then monitor patients during respective follow-ups. Nevertheless, diagnosis tracking and subsequent risk stratification often lend itself to significant subjectivity. Artificial intelligence (AI) can allow clinicians to recognize difficult relationships and manage enormous data sets, which is a task that is both extraordinarily difficult and time consuming for humans. By using AI algorithms and reducing the level of subjectivity, it is possible to use fewer resources while improving the overall efficiency and accuracy in prostate cancer diagnosis and management. Thus, this systematic review focuses on analyzing advancements in AI-based artificial neural networks (ANN) and their current role in prostate cancer diagnosis and management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ström, P., Kartasalo, K., Olsson, H., Solorzano, L., Delahunt, B., Berney, D. M., Bostwick, D. G., Evans, A. J., Grignon, D. J., Humphrey, P. A., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30738-7 · Cited by 620
Research works printed but not linked: 41
- Torre, 2015, CA Cancer J Clin, 65, 87, 10.3322/caac.21262 · DOI · Paper page
- Harmon, 2019, Diagn Interv Radiol, 25, 183, 10.5152/dir.2019.19125 · DOI · Paper page
- Harmon, 2019, Diagn Interv Radiol, 25, 183, 10.5152/dir.2019.19125 · DOI · Paper page
- Carroll, 2018, J Natl Compr Canc Netw, 16, 620, 10.6004/jnccn.2018.0036 · DOI · Paper page
- Partin, 1994, J Urol, 152, 1358, 10.1016/S0022-5347(17)32422-9 · DOI · Paper page
- Catalona, 1991, N Engl J Med, 324, 1156, 10.1056/NEJM199104253241702 · DOI · Paper page
- Djavan, 2002, J Clin Oncol, 20, 921, 10.1200/JCO.2002.20.4.921 · doi:10.1200/jco.2002.20.4.921 · Paper page
- Stojadinovic, 2018, Srp Arh Celok Lek, 147, 39
- Finne, 2000, Urology, 56, 418, 10.1016/S0090-4295(00)00672-5 · DOI
- Ge P, Gao F, Chen G. Predictive models for prostate cancer based on logistic regression and artificial neural network. 2015 IEEE International Conference on Mechatronics and Automation (ICMA). 2015;1472–1477. · doi:10.1109/icma.2015.7237702
- Stephan, 2002, Clin Chem, 48, 1279, 10.1093/clinchem/48.8.1279 · DOI
- Humphrey, 2017, Cold Spring Harb Perspect Med, 7, a030411, 10.1101/cshperspect.a030411 · DOI · Paper page
- Waliszewski, 2015, Prostate, 75, 399, 10.1002/pros.22926 · DOI
- Lawrentschuk, 2011, Int Urol Nephrol, 43, 23, 10.1007/s11255-010-9750-7 · doi:10.1007/s11255-010-9750-7
- Rodvold, 2001, Prostate, 46, 39, 10.1002/1097-0045(200101)46:1<39::AID-PROS1006>3.0.CO;2-M · DOI · Paper page
- Remzi, 2003, Urology, 62, 456, 10.1016/S0090-4295(03)00409-6 · DOI
- Moore, 2014, Curr Opin Urol, 24, 280, 10.1097/MOU.0000000000000040 · doi:10.1097/mou.0000000000000040
- Sato, 2005, J Magn Reson Imaging, 21, 258, 10.1002/jmri.20251 · DOI · Paper page
- Fehr, 2015, Proc Natl Acad Sci U S A, 112, E6265, 10.1073/pnas.1505935112 · DOI · Paper page
- Antonelli, 2019, Eur Radiol, 29, 4754, 10.1007/s00330-019-06244-2 · DOI
- Toivonen, 2019, PLoS One, 14, e0217702, 10.1371/journal.pone.0217702 · DOI
- Choyke, 2017, Oncology (Williston Park), 31, 67
- Jin, 2020, Mediators Inflamm, 2020, 8730608, 10.1155/2020/8730608 · doi:10.1155/2020/8730608
- McDonald, 2018, Prostate, 78, 411, 10.1002/pros.23485 · doi:10.1002/pros.23485
- Martignano, 2017, Clin Chim Acta, 473, 96, 10.1016/j.cca.2017.08.009 · DOI
- Jakobsen, 2016, J Clin Urol, 9, 3, 10.1177/2051415816656121 · DOI
- Filella, 2016, Int J Mol Sci, 17, 10.3390/ijms17111784 · DOI
- Reed, 2010, Expert Rev Anticancer Ther, 10, 103, 10.1586/era.09.168 · DOI
- Margreiter, 2008, Minerva Urol Nefrol, 60, 51
- Parekh, 2007, J Urol, 178, 2252, 10.1016/j.juro.2007.08.055 · DOI
- Shariat, 2007, Future Oncol, 3, 449, 10.2217/14796694.3.4.449 · DOI
- Stephan, 2007, Cancer Lett, 249, 18, 10.1016/j.canlet.2006.12.031 · doi:10.1016/j.canlet.2006.12.031
- Fruge, 2020, Front Oncol, 10, 544201, 10.3389/fonc.2020.544201 · DOI
- Green, 2016, Br J Cancer, 115, 236, 10.1038/bjc.2016.169 · DOI
- Kim, 2016, Nat Commun, 7, 11906, 10.1038/ncomms11906 · DOI · Paper page
- Auffenberg, 2019, Eur Urol, 75, 901, 10.1016/j.eururo.2018.09.050 · DOI
- Alitto, 2017, Future Oncol, 13, 2171, 10.2217/fon-2017-0142 · DOI
- Neeraj, 2017, Proc SPIE
- Naguib, 1998, Br J Cancer, 78, 246, 10.1038/bjc.1998.472 · DOI
- Gustavsen, 2020, Future Oncol, 16, 4265, 10.2217/fon-2019-0639 · DOI
- Liberati A, Altman D, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of clinical epidemiology. 2009;62:(10). · DOI · Paper page
Cited by
An Examination of the Use of Large Language Models to Aid Analysis of Textual Data
(2024) · doi:10.1177/16094069241231168 · Cited by 227
Schmidt, E., Putora, P. M., & Fijten, R. (2025) · Philosophy & Technology · doi:10.1007/s13347-024-00834-9 · Cited by 14
“For instance, AI-based applications are becoming more pro - ficient in predicting health-related outcomes such as diagnosing diseases like lung cancer (Patel et al., 2019 ) or predicting cancer recurrence for a specific patient (Van Booven et al., 2021 ).”
Rho, M. J., Park, J., Moon, H. W., Kim, C.-S., Jeon, S. S., Kang, M., & Lee, J. Y. (2022) · Prostate International · doi:10.1016/j.prnil.2021.09.001 · Cited by 5
Metadata
- Authors
- Van Booven, D. J., Kuchakulla, M., Pai, R., Frech, F. S., Ramasahayam, R., Reddy, P., Parmar, M., Ramasamy, R., & Arora, H.
- Venue
- Research and Reports in Urology
- Publisher
- Informa UK Limited
- Published
- 2021-01
- Volume
- Volume 13
- Pages
- 31-39
- ISSN
- 1179-1551 (ISSN-L)
- 2253-2447
- OpenAlex
- W3122808534
- Cited by
- 77
- References
- 1
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Systematic Review of Artificial Intelligence in Prostate Cancer. https://app.cochat.ai/papers/10.2147/rru.s268596
- The paper
- Van Booven, D. J., Kuchakulla, M., Pai, R., Frech, F. S., Ramasahayam, R., Reddy, P., Parmar, M., Ramasamy, R., & Arora, H. (2021). A Systematic Review of Artificial Intelligence in Prostate Cancer. Research and Reports in Urology. https://doi.org/10.2147/rru.s268596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.